Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography

Arch Phys Med Rehabil. 2009 May;90(5):741-4. doi: 10.1016/j.apmr.2008.10.025.

Abstract

Objective: To investigate the accuracy of manual needle placement into gastrocnemius muscle (GCM) for botulinum toxin type A (BTX-A) injection in children with spastic cerebral palsy (CP).

Design: Prospective clinical study.

Setting: University-affiliated hospital.

Participants: A total of 272 injections in GCMs of 39 children with spastic CP who were scheduled to receive BTX-A injections in GCMs.

Intervention: Not applicable.

Main outcome measures: The accuracy of manual needle placement was checked against ultrasonography.

Results: The needle was accurately inserted into GCM muscles in 78.7% of cases. Accuracy was 92.6% into gastrocnemius medialis (GM) and 64.7% into gastrocnemuis lateralis (GL). Muscle thickness at the needle insertion site was significantly thinner in GL than GM. Accuracy of GL in the younger age group (<4y, 57.6%) was lower than in the older age group (> or =4y, 78.1%). For GM, accuracy in both younger and older age groups was good (>90%).

Conclusions: Injection of the toxin into GCMs through the use of anatomic landmark was acceptable in GM, but not acceptable in GL, especially in young children.

Publication types

  • Clinical Trial

MeSH terms

  • Age Factors
  • Botulinum Toxins, Type A / administration & dosage*
  • Cerebral Palsy / diagnostic imaging
  • Cerebral Palsy / drug therapy*
  • Cerebral Palsy / rehabilitation
  • Child
  • Child, Preschool
  • Confidence Intervals
  • Electromyography
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Injections, Intramuscular
  • Logistic Models
  • Male
  • Muscle Relaxation / drug effects
  • Muscle Spasticity
  • Muscle, Skeletal / diagnostic imaging*
  • Muscle, Skeletal / drug effects*
  • Needles
  • Odds Ratio
  • Probability
  • Prospective Studies
  • Risk Assessment
  • Sensitivity and Specificity
  • Treatment Outcome
  • Ultrasonography

Substances

  • Botulinum Toxins, Type A